GALECTO BIOTECH ApS: Financial statements 2013
CVR: 34878366
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -14,954,230 and a net result of DKK -17,074,022. Equity in the 2013 report amounted to DKK -18,575,895.
- Gross Profit
- DKK -14,954,230
- Profit/Loss
- DKK -17,074,022
- Equity
- DKK -18,575,895
- Total Assets
- DKK 11,791,216
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of GALECTO BIOTECH ApS.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of GALECTO BIOTECH ApS.
GALECTO BIOTECH ApS has published its interim report for the period December 3, 2012 – December 31, 2012.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.